Bone-Derived FGF23 Promotes Tumor Progression and Bone Disease In Multiple Myeloma

被引：0
|
作者：
Anloague, Aric [1 ]
Sabol, Hayley M. [1 ]
Kaur, Japneet [2 ]
Khan, Sharmin [1 ]
Ashby, Cody [2 ,3 ]
Schinke, Carolina [4 ,5 ]
Barnes, C. Lowry [6 ]
Ambrogini, Elena [7 ]
Bellido, Teresita M. [1 ]
Delgado-Calle, Jesus [2 ]
机构：
[1] Univ Arkansas Med Sci, Dept Physiol & Cell Biol, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA
[4] Winthrop P Rockefeller Canc Inst, Little Rock, AR USA
[5] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR 72205 USA
[6] Univ Arkansas Med Sci, Dept Orthoped Surg, Little Rock, AR 72205 USA
[7] Univ Arkansas Med Sci, Div Endocrinol & Metab, Little Rock, AR USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1007
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Variation in the fibroblast growth factor 23 (FGF23) gene associates with serum FGF23 and bone strength in infants
    Enlund-Cerullo, Maria
    Holmlund-Suila, Elisa
    Valkama, Saara
    Hauta-alus, Helena
    Rosendahl, Jenni
    Andersson, Sture
    Pekkinen, Minna
    Makitie, Outi
    FRONTIERS IN GENETICS, 2023, 14
  • [22] The receptor tyrosine kinase Mer promotes multiple myeloma progression and osteolytic bone disease
    Engelmann, J.
    Ben Batalla, I.
    Taipaleenmaeki, H.
    Riecken, K.
    Gensch, V.
    Paesler, S.
    Berenbrok, N.
    Vargas, M. E.
    Waizenegger, J.
    Fehse, B.
    Pantel, K.
    Darwish, I.
    Bhamidipati, S.
    Masuda, E.
    Bokemeyer, C.
    Hesse, E.
    Loges, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 190 - 190
  • [23] The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer's Disease
    Yuan, Jun
    Meloni, Bruno P.
    Shi, Tianxing
    Bonser, Anne
    Papadimitriou, John M.
    Mastaglia, Frank L.
    Zhang, Changqing
    Zheng, Minghao
    Gao, Junjie
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (01) : 59 - 70
  • [24] Role of soluble bone-derived factors in mediating multiple myeloma growth and migration
    Xia, Y.
    Minuk, L.
    Chin-Yee, I
    Keeney, M.
    Allan, A. L.
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (3-4) : 220 - 220
  • [25] FGF23: a key player in mineral and bone disorder in CKD
    Komaba, H.
    Fukagawa, M.
    NEFROLOGIA, 2009, 29 (05): : 392 - 396
  • [26] Novel Regulators of Fgf23 Expression and Mineralization in Hyp Bone
    Liu, Shiguang
    Tang, Wen
    Fang, Jianwen
    Ren, Jinyu
    Li, Hua
    Xiao, Zhousheng
    Quarles, L. D.
    MOLECULAR ENDOCRINOLOGY, 2009, 23 (09) : 1505 - 1518
  • [27] Regulation of FGF23 and Bone Mass by the Proprotein Convertase Furin
    Al Rifai, Omar
    Essalmani, Rachid
    Creemers, John
    Seidah, Nabil G.
    Ferron, Mathieu
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 80 - 80
  • [28] Fgf23 and parathyroid hormone signaling interact in kidney and bone
    Andrukhova, Olena
    Streicher, Carmen
    Zeitz, Ute
    Erben, Reinhold G.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2016, 436 (0C) : 224 - 239
  • [29] Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications
    Salanova Villanueva, Laura
    Sanchez Gonzalez, Carmen
    Sanchez Tomero, Jose Antonio
    Aguilera, Abelardo
    Ortega Junco, Esther
    NEFROLOGIA, 2016, 36 (04): : 368 - 375
  • [30] FGF23 in Type 2 Diabetic Patients: Relationship With Bone Metabolism and Vascular Disease
    Reyes-Garcia, Rebeca
    Garcia-Martin, Antonia
    Garcia-Fontana, Beatriz
    Morales-Santana, Sonia
    Rozas-Moreno, Pedro
    Munoz-Torres, Manuel
    DIABETES CARE, 2014, 37 (05) : E89 - E90
12345